BioNTech Financial Records: Earnings Drop, Job Cuts, and Future Cancer Therapies
The German Biotech company BioNTech which gained recognition for the vaccine for COVID-19, shifted the significant performance by revealing its books. The company highlighted the declined profits and has announced plans to reconstruct to excel for market expectations. BioNTech’s Q4 2024 Financial Report: Key Highlights Why Are BioNTech’s Profits Declining? Job Cuts and Restructuring Plans … Read more